Read more
6:01 PM ยท 13 January 2025

Moderna slumps 20% on harsh 2025 guidance revision ๐Ÿ“‰

-
-
Open account Download free app
Moderna (MRNA.US) started the week with an exceptionally dismal session, with a stock declining around 20%. Investors are selling off shares of the mRNA vaccine producer following...

Log in or create a free account to keep reading

Analyses by award-winning experts

Create account  Log in
Join over 2 000 000 XTB Group Clients from around the world
The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissรฃo de Valores Mobiliรกrios (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits